Journals / Klinik Psikofarmakoloji Bülteni / 2015 / Cilt: 25 - Sayı: 1

Is interferon-ınduced psychotic depression associated with extra-pyramidal sensitivity?

Pages
91–92
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

TAYMUR, İ., İNEL, A., DAĞLI, Ö., GÜNGÖR, B. B., SARI, S., BURCU, A. N., AŞKIN, R. (2022). Is interferon-ınduced psychotic depression associated with extra-pyramidal sensitivity?. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 1, 91–92. https://ajindex.com/articles/573981

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, et al. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 2005;66(1):41-8. [CrossRef] 2. Barbarino A, Colasanti S, Corsello SM, Satta MA, Della Casa S, Rota CA. Dexamethasone inhibition of interferon- alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome. J Clin Endocrinol Metab 1995;80(4):1329-32. 3. Drozdz W, Borkowska A, Wilkosc M, Halota W, Dybowska D, Rybakowski JK. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report. Pharmacopsychiatry 2007;40(4):146-8. [CrossRef] 4. Quarantini LC, Miranda-Scippa A, Parana R, Sampaio AS, Bressan RA. Acute dystonia after injection of pegylated interferon alpha-2b. Mov Disord 2007;22(5):747-8. [CrossRef] 5. Ho BT, Huo YY, Lu JG, Tansey LW, Levin VA. Opioid- dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha. Pharmacol Biochem Behav 1992;42(1):57-60. [CrossRef]